SCHEMBL14252597

SCHEMBL14252597

CC(C)[SiH](C)O[C@H]1[C@@H](O[Si](C)(C)C(C)C)[C@H](n2cnc3c(N)nc(Cl)nc32)O[C@@H]1CO[Si](C)(C)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 6/20 0.50
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA9 Q16790 1/20 0.46
PDE2A O00408 4/20 0.45
ADORA2A P29274 2/20 0.45
ADORA1 P30542 2/20 0.45
ADORA2B P29275 1/20 0.45
ADRA1A P35348 1/20 0.44
PDE4D Q08499 1/20 0.44
PDE3A Q14432 1/20 0.44
NT5E P21589 5/20 0.44
CD99 P14209 1/20 0.44
P2RY1 P47900 2/20 0.42
P2RY11 Q96G91 2/20 0.42
IARS1 P41252 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4758281 0.91 ADORA3 (0.56) ADORA3CA1CA2CA4CA9
SCHEMBL4758255 0.81 ADORA3 (0.56) ADORA3CA1CA2CA4CA9
SCHEMBL4758245 0.79 ADORA3 (0.54) ADORA3CA1CA2CA4CA9
SCHEMBL4759360 0.77 ADORA3 (0.57) ADORA3CA1CA2CA4CA9
SCHEMBL4757814 0.76 ADORA3 (0.56) ADORA3CA1CA2CA4CA9
SCHEMBL24026358 0.74 ADORA3 (0.59) ADORA3CA1CA2CA4CA9
SCHEMBL14252588 0.73 ADORA3 (0.74) ADORA3CA1CA2CA4CA9
SCHEMBL7198801 0.69 ADORA3 (0.72) ADORA3CA1CA2CA4CA9
SCHEMBL3437027 0.69 ADORA3 (0.72) ADORA3CA1CA2CA4CA9
SCHEMBL19470039 0.69 DNMT1 (0.48) ADORA2AADORA2BALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342003-B2 Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) 2008-03-11 US disclosed